Home
About Us
Products
R & D
CSR
Global
Knowledge Desk
Payments
ADR Reporting
Medical Conference
Contact Us
Updates
ARISTO
has registered highest growth rate (14.55%) among top 12 pharmaceutical companies in India (Source-IMS MAT April 2017)
ARISTO
is ranked No. 3 in its covered market (Source-IMS MAT April 2017)
ARISTO
continues to be among the top 10 companies of India as per SMSRC prescription audit
ARISTO
has introduced India’s 1st ready-to-use, multi-dose probiotic formulation ‘Darolac Syrup’ in association with Royal Holloway University of London
ARISTO
has launched ready-to-drink, WHO recommended ORS formula ‘Olyte ORS’.
ARISTO
has entered anticoagulant segment with the launch of ‘Fondum’ PFS
Featured
ARISTO
is ranked No. 3 in its covered market (Source-IMS MAT April 2017)
Share
Posted:
June 19, 2017 at 9:20 am / by
@Aristo
/
comments (0)
tags:
error:
Content is protected !!